Symbol="BEAM"
AssetType="Common Stock"
Name="Beam TherapeuticsÂ Inc"
Description="Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. The company is headquartered in Cambridge, Massachusetts."
CIK="1745999"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="26 LANDSDOWNE STREET, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1947357000"
EBITDA="-364484000"
PERatio="None"
PEGRatio="None"
BookValue="10.71"
DividendPerShare="0"
DividendYield="0"
EPS="-4.51"
RevenuePerShareTTM="1.107"
ProfitMargin="0"
OperatingMarginTTM="-4.758"
ReturnOnAssetsTTM="-0.172"
ReturnOnEquityTTM="-0.37"
RevenueTTM="80160000"
GrossProfitTTM="-250674000"
DilutedEPSTTM="-4.51"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.208"
AnalystTargetPrice="65.36"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="32.42"
PriceToBookRatio="4.426"
EVToRevenue="24.39"
EVToEBITDA="-7.47"
Beta="1.56"
num_52WeekHigh="69.97"
num_52WeekLow="24.35"
num_50DayMovingAverage="31.22"
num_200DayMovingAverage="36.94"
SharesOutstanding="76218000"
DividendDate="None"
ExDividendDate="None"
symbol="BEAM"
open="25.13"
high="25.31"
low="24.35"
price="25.22"
volume="898272.00"
latest_trading_day="2023-08-14"
previous_close="25.55"
change="-0.33"
change_percent="-1.2916%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="63"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="37"
Volume_recent_avg="865675"
Change_recent_avg="-0.09"
Delta_recent_avg="1.41"
Variance_recent_avg="0.7"
Change_ratio_recent_avg="-0.35"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="37"
Aroon_momentum_negative="63"
image_negative_thumbnail_id_1="1100"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0133.jpeg"
image_negative_thumbnail_id_2="487"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0118.jpeg"
image_neutral_thumbnail_id_1="552"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_neutral_thumbnail_id_2="547"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0052.jpeg"
image_positive_thumbnail_id_1="998"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0160.jpeg"
image_positive_thumbnail_id_2="982"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0144.jpeg"
image_professor_thumbnail_id_1="1172"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
image_professor_thumbnail_id_2="1201"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
